EN | RU
EN | RU

Help Support

Баннер конференции
Lyophilizate of injection solution 20mg №3

Lyophilizate of injection solution 20mg №3

  • 15 minutes after intramuscular administration, the concentration of tenoxicam reaches 90% of the maximum possible value [1]
  • Has anti-inflammatory, analgesic action [3,4,5,8]
  • Helps block matrix prostaglandin E2 synthetase and COX-2 [6,7]

Texared tablets 20 mg №10

Texared tablets 20 mg №10

  • Ease of use - 1 time per day [1,2]
  • Wide range of indications [1,2]
  • Helps block free radicals [8,9]
  • Reduces the activity of collagenase and proteoglycanase [10,11]

Texared®1 dosage - 1 time per day [1,2] Wide range of indications [1,2]

Texared®1 dosage - 1 time per day [1,2] Wide range of indications [1,2]

1. Instructions for medical use of the drug Texared® lyophilisate for the preparation of a solution for injection 20 mg No. 3, RU LS-000295 dated 16.07.21
2. Instructions for medical use of the drug Texared ® tablets 20 mg No. 10, RU LS-000294 dated 10/15/21

The information is intended for medical and pharmaceutical workers

Know More
Sequential scheme for the use of the drug Texared®

Sequential scheme for the use of the drug Texared®

1. Instructions for medical use of the drug Texared® lyophilisate for the preparation of a solution for injection 20 mg No. 3, RU LS-000295 dated 16.07.21
2. Instructions for medical use of the drug Texared ® tablets 20 mg No. 10, RU LS-000294 dated 10/15/21
*Acute musculoskeletal disorders usually do not require therapy for more than 7 days, but in severe cases it can be continued, up to a maximum of 14 days. (Instruction for the medical use of the drug Texared® tablets 20 mg No. 10, RU LS-000294 dated 10/15/21).

The information is intended for medical and pharmaceutical workers

Know More
Texared®. 100% bioavailability for 2 forms [2,3]

Texared®. 100% bioavailability for 2 forms [2,3]

15 minutes after intramuscular administration, the concentration of tenoxicam reaches 90% of the maximum possible value [1,2]

1. Instructions for medical use of the drug Texared® lyophilisate for the preparation of a solution for injection 20 mg No. 3, RU LS-000295 dated 16.07.21
2. Instructions for medical use of the drug Texared ® tablets 20 mg No. 10, RU LS-000294 dated 10/15/21
3. Instructions for medical use of the drug Movalis ® injection RU P N012978/01 dated 31.03.17; Movalis tablets RU P No. N012978/01 dated 05/28/21

The information is intended for medical and pharmaceutical workers

Know More
Texared® tablets 20 mg №10

Texared® tablets 20 mg №10

* https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=a0772943-769d-44f5-a48a-c18c936e001a (accessed 06/01/2022)

1. Instructions for medical use of the drug Texared ® tablets 20 mg No. 10, RU LS-000294 dated 10/15/21

The information is intended for medical and pharmaceutical workers

Know More

Materials (4)

227
Material Material
Summaries

Efficacy of different doses of Tenoxicam to prevent Propofol inje...

This prospective randomized study was conducted with the objective of comparing the effects of two different dosages of Tenoxicam (NSAID) to prev...

336
Material Material
Summaries

Tenoxicam: An Update on its Therapeutic Efficacy in Rheumatic Dis...

Rheumatic diseases involve around 150 types that are majorly linked with pain, morbidity, and disability that could lead to loss of work.

226
Material Material
Summaries

Comparative efficacy and safety of Tenoxicam with other NSAIDs

Tenoxicam belongs to the class of NSAIDs called oxicams. 

2096
Material Material
Drug Reference

Tenoxicam

Tenoxicam belongs to the class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs). 

LIST OF ABBREVIATIONS

1. Instructions for the medical use of the drug Texared® lyophilizate for the preparation of a solution for injection 20 mg No. 3, RU LS-000295 dated 16.07.21

2. Instructions for the medical use of the drug Texared ® tablets 20 mg No. 10, RU LS-000294 dated 10/15/21

3. Gonzalez JP, Todd PA. Tenoxicam: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. drugs. 1987; 34:289-310.

4. Tanaka Y, Himori N. Analgesic actions of tenoxicam in various inflammatory animal models. Japanese Pharmacology and Therapeutics. 1988; 16:43-55

5. Drugs Therapy Perspectives, 2000

6. Xu S, Rouzer CA, Marnett LJ. IUBMB Life. Dec 2014; 66(12): 803-811

7. Braga PC, Biella G, Tiengo M. Effects of tenoxicam on nociceptive thalamic neuronal firing in arthritic rats. Drugs under Experimental and Clinical Research. 1987; 13:389-398

8. Instructions for the medical use of the drug Texared® lyophilizate for the preparation of a solution for injection 20 mg No. 3, RU LS-000295 dated 16.07.21

9. "Observational study to evaluate the efficacy and safety of tenoxicam in dorsalgia in comparison with meloxicam and diclofenac sodium" Rachin A.P. Breast cancer No. 4 dated 11/27/18

10. Vignon E, Mathieu P, Louisot P, Richard M. In vitro effect of nonsteroidal antiinflammatory drugs on proteoglycanase and collagenase activity in human osteoarthritic cartilage. Arthritis Rheum. 1991 Oct;34(10):1332-5.

11. Ozgocmen S, Ardicoglu O, Erdogan H, Fadillioglu E, Gudul H. In vivo effect of celecoxib and tenoxicam on oxidant/ anti-oxidant status of patients with knee osteoarthritis. Ann Clinic Lab Sc. 2005;35(2):137-143

Try: